International Affairs Committee
Activity Report

Latest information

Contribution: Article to Cytotherapy by APACRM Working…
Report: AusBiotech 2022
Contribution: Meeting summary to Cytotherapy by the 4th…
Click here for past updates

Management Policy/Role

We will support the international partnership and expansion of member companies, accelerate product creation and business development, and contribute to the promotion of industrialization in the field of regenerative medicine, for the purpose to achieve the FIRM’s objective. In addition, we will promote regulatory harmonization of Asian countries and regions together with the regulatory authorities in order to realize an Asian market comparable to those in North America and Europe.